[Experimental oxalic lithiases in rats. Influence of certain Krebs cycle intermediates].
D000284:Administration, Oral; D000818:Animals; D002951:Citrates / Q000008:administration & dosage*; D002952:Citric Acid Cycle; D004195:Disease Models, Animal; D005026:Ethylene Glycols; D006038:Glyoxylates; D006909:Hydroxyproline; D007274:Injections, Intraperitoneal; D007669:Kidney Calculi / Q000139:chemically induced / Q000517:prevention & control*; D008293:Malates / Q000008:administration & dosage* / Q000627:therapeutic use; D010070:Oxalates; D010071:Oxaloacetates / Q000008:administration & dosage* / Q000627:therapeutic use; D051381:Rats; D013386:Succinates / Q000008:administration & dosage* / Q000627:therapeutic use
D002951:Citrates; D005026:Ethylene Glycols; D006038:Glyoxylates; D008293:Malates; D010070:Oxalates; D010071:Oxaloacetates; D013386:Succinates; D006909:Hydroxyproline
Lithiases oxaliques expérimentales du rat. Influence de certains intermédiaires du cycle de krebs